WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Tuesday, March 31, 2020 
Add Press Release News | News Feeds Feeds | Email This News Email


Global COVID-19 (Coronavirus) Pipeline Scenario & Growth Prospects, 2020 - Analysis by Development Stage, Mechanism of Action, Route of Administration and Molecule Type
Tuesday, March 31, 2020

DUBLIN, March 25, 2020 /PRNewswire/ -- The "COVID-19 (Coronavirus) - Pipeline Insight, 2020" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This COVID-19 (Coronavirus) - Pipeline Insight, 2020 report outlays comprehensive insights of present scenario and growth prospects across COVID-19. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type.

Products covered by Phase

    --  Phase III, Phase II, Phase I
    --  Pre-clinical & Discovery
    --  Inactive (Discontinued and Dormant)

Overview of Pipeline Development Activities for COVID-19 (Coronavirus)

Pipeline analysis of therapeutic drugs includes but is not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology, and patent details.

Therapeutic Segmentation of Products for COVID-19 (Coronavirus)

The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

Methodology

Data used in the report are sourced primarily from internal databases, primary & secondary research, and in-house analysis by a team of industry experts.

Information and data from the secondary sources have been obtained from various printable & non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals, and access to available databases.

Scope of the Report

    --  Provides an overview of therapeutic pipeline activity for COVID-19
        (Coronavirus) across the complete product development cycle including
        all clinical and non-clinical stages
    --  It comprises of detailed profiles of COVID-19 (Coronavirus) therapeutic
        products with key coverage of developmental activities including
        licensing & collaboration deals, patents issued, designations,
        technologies, and chemical information
    --  Therapeutic assessment of the active pipeline products by stage, product
        type, molecule type, and route of administration
    --  Coverage of dormant and discontinued pipeline projects across COVID-19
        (Coronavirus)

Reasons to Buy

    --  Establish a comprehensive understanding of the current pipeline scenario
        across COVID-19 (Coronavirus) to formulate effective R&D strategies
    --  Assess challenges and opportunities that influence COVID-19
        (Coronavirus) R&D
    --  Gather impartial perspective of strategies of the emerging competitors
        having a potentially lucrative portfolio in this space and create
        effective counter-strategies to gain competitive advantage
    --  Identify the relationship between the product and use it for target
        finding, drug repurposing, and precision medicine
    --  Devise in-licensing and out-licensing strategies by identifying
        prospective partners with progressing projects for COVID-19
        (Coronavirus) to enhance and expand business potential and scope
    --  The extensive domain knowledge on therapy areas support the client in
        the decision-making process regarding their therapeutic portfolio by
        identifying the reason behind the inactive or discontinued drugs

Key Topics Covered

1. Report Introduction

2. COVID-19 (Coronavirus) - Disease Overview

3. Pipeline Outlook

    --  An Overview of Pipeline Products for COVID-19 (Coronavirus)

4. Comparative Analysis

5. COVID-19 (Coronavirus) Therapeutic Products in Clinical Stage

    --  Drug Name: Company Name
    --  Product Description
    --  Research and Development
    --  Product Development Activities

6. COVID-19 (Coronavirus) Therapeutic Products in Non-clinical Stage

    --  Drug Name: Company Name
    --  Product Description
    --  Research and Development
    --  Product Development Activities

7. Therapeutic Pipeline Analysis

    --  Pipeline Analysis by Route of Administration
    --  Pipeline Analysis by Stage and Route of Administration
    --  Pipeline Analysis by Molecule Type
    --  Pipeline Analysis by Stage and Molecule Type

8. Inactive Pipeline Products

    --  Drug Description
    --  Research and Development Studies
    --  Product Development Activities
    --  Reason for dormancy/discontinuation

List of Tables
Table 1: Total Pipeline Products for COVID-19 (Coronavirus)
Table 2: COVID-19 (Coronavirus) Therapeutic Products in Clinical Stage
Table 3: COVID-19 (Coronavirus) Therapeutic Products in Non-clinical Stage
Table 4: Pipeline Analysis by Route of Administration
Table 5: Pipeline Analysis by Stage and Route of Administration
Table 6: Pipeline Analysis by Molecule Type
Table 7: Pipeline Analysis by Stage and Molecule Type
Table 8: Inactive Products

List of Figures
Figure 1: Total Products for COVID-19 (Coronavirus)
Figure 2: COVID-19 (Coronavirus) Therapeutic Products in Clinical Stage
Figure 3: COVID-19 (Coronavirus) Therapeutic Products in Non-clinical Stage
Figure 4: Pipeline Analysis by Route of Administration
Figure 5: Pipeline Analysis by Stage and Route of Administration
Figure 6: Pipeline Analysis by Molecule Type
Figure 7: Pipeline Analysis by Stage and Molecule Type
Figure 8: Inactive Products

For more information about this report visit https://www.researchandmarkets.com/r/rg65pp

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-covid-19-coronavirus-pipeline-scenario--growth-prospects-2020---analysis-by-development-stage-mechanism-of-action-route-of-administration-and-molecule-type-301029610.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Informatica Launches New Intelligence and Automation Innovations Across the Intelligent Data Platform | Mar 31, 2020
Nav Global Combined Heat & Power Industry | Mar 31, 2020
Nav Microservices Architecture Market to Reach $8.07 Bn, Globally, by 2026 at 18.6% CAGR: Allied Market Research | Mar 31, 2020
Nav With Recession Looming, the Three Biggest Mistakes Procurement & Supply Chain Leaders Must Avoid | Mar 31, 2020
Nav Outlook into the Worldwide Oral Vaccine Market to 2025 - Featuring GlaxoSmithKline, PaxVax and Shanghai BravoBio Among Others | Mar 31, 2020
Nav Global CMOS Image Sensor Industry | Mar 31, 2020
Nav 2020 Pipeline Insight on Insulin Resistance | Mar 31, 2020
Nav Global docking station market is expected to grow with a CAGR of 6% over the forecast period from 2019-2025 | Mar 31, 2020
Nav Global diet soft drinks market is expected to grow with a CAGR of 4% over the forecast period from 2019-2025 | Mar 31, 2020
Nav Global meal replacement products market is expected to grow with a CAGR of 8% over the forecast period from 2019-2025 | Mar 31, 2020
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News